| Literature DB >> 30394117 |
Cristiane Martinez Ruiz Pegoraro1, Gisele Alborghetti Nai2, Leonardo Alves Garcia3, Fernanda de Maria Serra4, Juliana Apolônio Alves3, Pedro Henrique Nahas Chagas3, Décio Gomes de Oliveira5, Marcos Alberto Zocoler5.
Abstract
The aim of this study was to assess the protective effects of oral and topical treatment with Bidens pilosa (BP) against carbon tetrachloride (CCl4)- induced toxicity. Fifty-six rats were divided into seven groups: A: CCl4 only; B: CCl4+oral BP; C: CCl4 and topical BP; D: CCl4+oral and topical BP; E: oral BP only; F: negative control; and G: positive control (cyclophosphamide). The animals were treated for 10 weeks. Blood samples were collected for tests of hepatic and renal function, and fragments of the liver, spleen, pancreas, kidney, and intestine were collected for histopathological analyses. Cells from the femoral bone marrow were used for a micronucleus test and 'comet assay'. Statistically significant differences were observed in the levels of gamma-glutamyl transpeptidase (GGT), albumin, urea and creatinine, hepatic inflammation, renal tubular lesion, and inflammation of the intestinal mucosa between the BP-treated groups and untreated group. The median number of micronuclei in group A was 4.00, in group G was 9.00 and in the other groups was 0.00. Group A had the lowest number of cells with a score of 0 and the greatest number with scores of 3 and 4, similar to the results obtained from group G using the 'comet assay'. Thus, BP effectively protected against the toxic effects of CCl4 on the liver, kidney, and intestine and exerted an antimutagenic effect on rats exposed to CCl4.Entities:
Keywords: Bidens pilosa; carbon tetrachloride; cyclophosphamide; genotoxicity; liver
Mesh:
Substances:
Year: 2018 PMID: 30394117 DOI: 10.1080/01480545.2018.1526182
Source DB: PubMed Journal: Drug Chem Toxicol ISSN: 0148-0545 Impact factor: 3.356